Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Current Assets (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Current Assets of $26.9 million for Q4 2025, down 58.02% year-over-year from $64.1 million in Q4 2024, and down 58.93% quarter-over-quarter from $65.5 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Current Assets (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Current Assets for 4 consecutive years, with $26.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Assets fell 58.02% year-over-year to $26.9 million; the TTM figure through Dec 2025 stood at $26.9 million (down 58.02% YoY), while the FY2025 annual figure was $26.9 million, down 58.02% from the prior year.
  • Current Assets eased to $26.9 million in Q4 2025 per ANL's latest filing, from $65.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $101.2 million in Q4 2023 and bottomed at $26.9 million in Q4 2025.
  • Historically, Current Assets has averaged $70.7 million across 4 years, with a median of $65.9 million in 2022.
  • Annual changes were most pronounced in 2023 — Current Assets jumped 52.63% — and 2025, when it slumped 58.02%.
  • Adlai Nortye's Current Assets stood at $66.3 million in 2022, then soared by 52.63% to $101.2 million in 2023, then slumped by 36.69% to $64.1 million in 2024, then plunged by 58.02% to $26.9 million in 2025.
  • Business Quant data shows ANL's Current Assets at $26.9 million in Q4 2025, $65.5 million in Q2 2025, and $64.1 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 12.54 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 18.45 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 8.07 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.82 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.03 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 7.22 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.62 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.76 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.63 Bn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 240.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 240.88 Mn
Dec 31, 2025 26.89 Mn
Jun 30, 2025 65.48 Mn
Dec 31, 2024 64.06 Mn
Jun 30, 2024 100.28 Mn
Dec 31, 2023 101.20 Mn
Dec 31, 2022 66.30 Mn